Physician profile
Robert Wendel
NPI 1235234634
$4,008.01
in general payments reported to CMS, 2019-2025
16 companies · $384 in 2025
The $384 reported for 2025 was less than what a typical Retina Specialist provider received nationally (typical 2025 total: $460).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,538 · 2020: $436 · 2021: $15.96 · 2022: $371 · 2023: $624 · 2024: $637 · 2025: $384.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,646.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,645.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $760.24 | 2019-2025 | Vabysmo |
| Apellis Pharmaceuticals, INC. | $618.64 | 2022-2025 | Syfovre |
| Regeneron Healthcare Solutions, INC. | $559.02 | 2019-2024 | Eylea Hd, Eylea |
| Dutch Ophthalmic, USA | $500.00 | 2019 | |
| Alcon Vision LLC | $280.35 | 2019-2020 | |
| Astellas Pharma US INC | $229.29 | 2023-2025 | Izervay |
| Genentech, INC. | $210.99 | 2022-2025 | |
| Alimera Sciences, INC. | $207.22 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $204.75 | 2019-2020 | |
| Coherus Oncology, INC. | $125.00 | 2023 | |
| Regeneron Pharmaceuticals, INC. | $124.75 | 2022 | |
| Abbvie INC. | $87.29 | 2019 | |
| Amgen INC. | $38.65 | 2024-2025 | Pavblu |
| Johnson & Johnson Surgical Vision, INC. | $29.58 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $19.10 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $13.14 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Wendel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.